Postoperative Rheumatic Heart Disease Follow-Up: Creating a National Registry and First Results from Rwanda.


Journal

Annals of global health
ISSN: 2214-9996
Titre abrégé: Ann Glob Health
Pays: United States
ID NLM: 101620864

Informations de publication

Date de publication:
09 09 2020
Historique:
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 16 10 2021
Statut: epublish

Résumé

In many developing countries, rheumatic heart disease (RHD) is diagnosed at an advanced stage and requires surgery for patient survival. However, access to cardiac surgery in this context is limited and often provided through partnerships, requiring centralized patient data systems for monitoring and follow-up. This study used data from a national postoperative RHD registry to analyze clinical outcomes of Rwandan patients who received surgery between 2006 and 2017. The RHD registry was created in 2017 using data compiled from Rwanda Ministry of Health and RHD surgery partners. We extracted pre- and post-operative data on patients who were alive and in care. We excluded patients who died or were lost to follow-up, as their data was not collected in the registry. We evaluated the association between demographic, surgical, and follow-up characteristics and most recent patient symptoms, categorized by New York Heart Association (NYHA) class. Among the 191 patients eligible for inclusion in this study, 107(56.0%) were female, 110(57.6%) were adults at the time of surgery (>15 years), and 128(67.4%) had surgery in Rwanda. Most patients (n = 166, 86.9%) were on penicillin prophylaxis. Of the patients with mechanical valves, 47(29.9%) had therapeutic International Normalized Ratio values. 90% of patients were asymptomatic (NYHA I) at the time of most recent visit. NYHA class was not significantly associated with any of the considered variables. The median length of follow-up for patients was four years (IQR: 2, 5 years). This study shows both the feasibility and challenges of creating a RHD registry 11 years after the national initiation of RHD surgeries. Most patients captured in the registry are asymptomatic; however, collecting details on patients who had died or were lost to follow-up has proven difficult. Implementing strategies to maintain a complete and up-to-date registry will facilitate follow-up for pre- and postoperative patients.

Sections du résumé

Background
In many developing countries, rheumatic heart disease (RHD) is diagnosed at an advanced stage and requires surgery for patient survival. However, access to cardiac surgery in this context is limited and often provided through partnerships, requiring centralized patient data systems for monitoring and follow-up.
Objectives
This study used data from a national postoperative RHD registry to analyze clinical outcomes of Rwandan patients who received surgery between 2006 and 2017.
Methods
The RHD registry was created in 2017 using data compiled from Rwanda Ministry of Health and RHD surgery partners. We extracted pre- and post-operative data on patients who were alive and in care. We excluded patients who died or were lost to follow-up, as their data was not collected in the registry. We evaluated the association between demographic, surgical, and follow-up characteristics and most recent patient symptoms, categorized by New York Heart Association (NYHA) class.
Findings
Among the 191 patients eligible for inclusion in this study, 107(56.0%) were female, 110(57.6%) were adults at the time of surgery (>15 years), and 128(67.4%) had surgery in Rwanda. Most patients (n = 166, 86.9%) were on penicillin prophylaxis. Of the patients with mechanical valves, 47(29.9%) had therapeutic International Normalized Ratio values. 90% of patients were asymptomatic (NYHA I) at the time of most recent visit. NYHA class was not significantly associated with any of the considered variables. The median length of follow-up for patients was four years (IQR: 2, 5 years).
Conclusion
This study shows both the feasibility and challenges of creating a RHD registry 11 years after the national initiation of RHD surgeries. Most patients captured in the registry are asymptomatic; however, collecting details on patients who had died or were lost to follow-up has proven difficult. Implementing strategies to maintain a complete and up-to-date registry will facilitate follow-up for pre- and postoperative patients.

Identifiants

pubmed: 32963968
doi: 10.5334/aogh.2719
pmc: PMC7485403
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL140133
Pays : United States

Informations de copyright

Copyright: © 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Ann Med. 2012 May;44(3):253-61
pubmed: 21254894
Int J Cardiol. 2013 May 10;165(2):237-41
pubmed: 22464485
J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185
pubmed: 24603191
Eur Heart J. 2015 May 7;36(18):1115-22a
pubmed: 25425448
J Card Fail. 2018 Dec;24(12):849-853
pubmed: 30312764
Lancet Glob Health. 2014 Mar;2(3):e141-2
pubmed: 25102844
Arch Cardiovasc Dis. 2017 Feb;110(2):82-90
pubmed: 27720166
Cardiovasc J Afr. 2012 Apr;23(3):165-7
pubmed: 22555641
Heart. 2018 Oct;104(20):1707-1713
pubmed: 29678896
Heart. 2013 Nov;99(21):1554-61
pubmed: 23680886
Arch Cardiovasc Dis. 2016 May;109(5):321-9
pubmed: 26988837
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
Heart Asia. 2016 Apr 28;8(1):62-4
pubmed: 27326236
Glob Heart. 2013 Sep;8(3):185-6
pubmed: 25690493

Auteurs

Evariste Ntaganda (E)

Rwanda Biomedical Center, Kigali, RW.

Emmanuel Rusingiza (E)

University of Rwanda, College of Medicine and Health Sciences, Kigali, RW.

Gilbert Rukundo (G)

Partners In Health, Inshuti Mu Buzima, Kigali, RW.

Loise Ng'ang'a (L)

Partners In Health, Inshuti Mu Buzima, Kigali, RW.

Bethany Hedt-Gauthier (B)

Partners In Health, Inshuti Mu Buzima, Kigali, RW.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, US.

Ziad El-Khatib (Z)

University School of Medicine, Boston, US.
Karolinska Institutet, Stockholm, SE.

Gene F Kwan (GF)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, US.
University School of Medicine, Boston, US.

Ganza Gapira (G)

Rwanda Military Hospital, Kigali, RW.

Neil K Worrall (NK)

Healing Hearts Northwest, RW.

JaBaris Swain (J)

Team Heart, Inc, RW.

Abel Kagame (A)

Rwanda Heart Foundation, RW.

Cadet Mutumbira (C)

Rwanda Biomedical Center, Kigali, RW.

Nathan Ruhamya (N)

King Faisal Hospital, Kigali, RW.

Ceeya Bolman (C)

Team Heart, Inc, RW.

Jessica Sewase (J)

Team Heart, Inc, RW.

Gilles Ndayisaba (G)

Rwanda Biomedical Center, Kigali, RW.

R Morton Bolman Iii (RM)

Team Heart, Inc, RW.

Harold Goldberg (H)

Healing Hearts Northwest, RW.

Joseph Mucumbitsi (J)

Rwanda Heart Foundation, RW.
King Faisal Hospital, Kigali, RW.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH